Average Co-Inventor Count = 4.08
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Albireo Ab (8 from 57 patents)
2. Astrazeneca Ab (2 from 1,500 patents)
3. Aibireo Ab (1 from 1 patent)
4. Nps Pharmaceuticals, Inc. (93 patents)
5. Thomas M. Stormann (0 patent)
6. Jan Mattsson (0 patent)
7. Anders Lehmann (0 patent)
11 patents:
1. 12447156 - Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibitors
2. 12187690 - Benzothiadiazepine compounds and their use as bile acid modulators
3. 11773071 - Benzothiazepine compounds and their use as bile acid modulators
4. 11603359 - Benzothiadiazepine compounds and their use as bile acid modulators
5. 11583539 - Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibitors
6. 11306064 - Benzothia(di)azepine compounds and their use as bile acid modulators
7. 10975045 - Benzothiazepine compounds and their use as bile acid modulators
8. 10941127 - Benzothiadiazepine compounds and their use as bile acid modulators
9. 10793534 - Benzothia(di)azepine compounds and their use as bile acid modulators
10. 7964609 - Use of mGluR5 antagonists for the treatment of gerd
11. 7718686 - Imidazole variants as modulators of GABA receptor for the treatment of GI disorders